Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  pan-PI3K/mTOR inhibitor SF1126
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
SF1126 for Patients With Relapsed or Refractory Neuroblastoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 1 to 30
Trial IDs: NANT 2014-01, NCI-2015-01118, N14-01, NCT02337309
Start Over